[1]
|
Machida, H., Matsuo, K., Yamagami, W., et al. (2019) Trends and Characteristics of Epithelial Ovarian Cancer in Japan between 2002 and 2015: A JSGO-JSOG Joint Study. Gynecologic Oncology, 153, 589-596.
https://doi.org/10.1016/j.ygyno.2019.03.243
|
[2]
|
Takahashi, K., Takenaka, M., Kawabata, A., et al. (2020) Re-thinking of Treatment Strategies and Clinical Management in Ovarian Clear Cell Carcinoma. International Journal of Clinical Oncology, 25, 425-431.
https://doi.org/10.1007/s10147-020-01625-w
|
[3]
|
Pozzati, F., Moro, F., Pasciuto, T., et al. (2018) Imaging in Gy-necological Disease (14): Clinical and Ultrasound Characteristics of Ovarian Clear Cell Carcinoma Multicenter Study. Ultrasound in Obstetrics & Gynecology, 52, 792-800.
https://doi.org/10.1002/uog.19171
|
[4]
|
Yamamoto, A., Johnstone, E.B., Bloom, M.S., Huddleston, H.G. and Fu-jimoto, V.Y. (2017) A Higher Prevalence of Endometriosis among Asian Women does Not Contribute to Poorer IVF Outcomes. Journal of Assisted Reproduction and Genetics, 34, 765-774. https://doi.org/10.1007/s10815-017-0919-1
|
[5]
|
Machida, H., Matsuo, K., Yamagami, W., Ebina, Y., Kobayashi, Y., Tabata, T., et al. (2019) Trends and Characteristics of Epithelial Ovarian Cancer in Japan between 2002 and 2015: A JSGO-JSOG Joint Study. Gynecologic Oncology, 153, 589-596. https://doi.org/10.1016/j.ygyno.2019.03.243
|
[6]
|
Liu, H., Xu, Y., Ji, J., Dong, R., Qiu, H. and Dai, X. (2020) Prognosis of Ovarian Clear Cell Cancer Compared with Other Epithelial Cancer Types: A Population-Based Analysis. Oncology Letters, 19, 1947-1957.
https://doi.org/10.3892/ol.2020.11252
|
[7]
|
Zhu, C., Zhu, J., Qian, L., et al. (2021) Clinical Characteristics and Prognosis of Ovarian Clear Cell Carcinoma: A 10-Year Retrospective Study. BMC Cancer, 21, Article No. 322. https://doi.org/10.1186/s12885-021-08061-7
|
[8]
|
Ye, S., Yang, J., Cao, D., Bai, H., Huang, H., Wu, M., et al. (2015) Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study. PLOS ONE, 10, e0121818.
https://doi.org/10.1371/journal.pone.0121818
|
[9]
|
Swier, N. and Versteeg, H.H. (2017) Reciprocal Links between Venous Thromboembolism, Coagulation Factors and Ovarian Cancer Progression. Thrombosis Research, 150, 8-18. https://doi.org/10.1016/j.thromres.2016.12.002
|
[10]
|
Brilhante, A.V., Augusto, K.L., Portela, M.C., Sucupira, L.C., Oliveira, L.A., Pouchaim, A.J., Nóbrega, L.R., Magalhães, T.F. and Sobreira, L.R. (2017) Endometriosis and Ovarian Cancer: An Integrative Review (Endometriosis and Ovarian Cancer). Asian Pacific Journal of Cancer Prevention, 18, 11-16.
|
[11]
|
Tay, S.K. and Cheong, M.A. (2014) Evidence for Ethnic and Environmental Contributions to Frequency of Ovarian Clear Cell Carcinoma. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 54, 225-230.
https://doi.org/10.1111/ajo.12188
|
[12]
|
Prat, J. (2012) New Insights into Ovarian Cancer Pathology. Annals of On-cology, 23, x111-x117.
https://doi.org/10.1093/annonc/mds300
|
[13]
|
Kobayashi, H., Sumimoto, K., Moniwa, N., et al. (2007) Risk of De-veloping Ovarian Cancer among Women with Ovarian Endometrioma: A Cohort Study in Shizuoka, Japan. International Journal of Gynecological Cancer, 17, 37-43.
https://doi.org/10.1111/j.1525-1438.2006.00754.x
|
[14]
|
Varma, R., Rollason, T., Gupta, J.K., et al. (2004) Endo-metriosis and the Neoplastic Process. Reproduction, 127, 293-304. https://doi.org/10.1530/rep.1.00020
|
[15]
|
Van Gorp, T., Amant, F., Neven, P., et al. (2004) Endometriosis and the Development of Malignant Tumours of the Pelvis. A Review of Literature. Best Practice & Research Clinical Obstetrics & Gynaecology, 18, 349-371.
https://doi.org/10.1016/j.bpobgyn.2003.03.001
|
[16]
|
Kobayashi, H., Sumimoto, K., Kitanaka, T., et al. (2008) Ovarian Endometrioma: Risks Factors of Ovarian Cancer Development. The European Journal of Obstetrics & Gyne-cology and Reproductive Biology, 138, 187-193.
https://doi.org/10.1016/j.ejogrb.2007.06.017
|
[17]
|
Worley, J.M.J., Welch, W.R., Berkowitz, R.S. and Ng, S.-W. (2013) Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis. International Journal of Molecular Sci-ences, 14, 5367-5379.
https://doi.org/10.3390/ijms14035367
|
[18]
|
Bulun, S.E. (2009) Endometriosis. The New England Journal of Medi-cine, 360, 268-279.
https://doi.org/10.1056/NEJMra0804690
|
[19]
|
Yamaguchi, K., Mandai, M., Oura, T., Matsumura, N., Hamanishi, J., Baba, T., Matsui, S., Murphy, S.K. and Konishi, I. (2010) Identification of an Ovarian Clear Cell Carcinoma Gene Signature that Reflects Inherent Disease Biology and the Carcinogenic Processes. Oncogene, 29, 1741-1752. https://doi.org/10.1038/onc.2009.470
|
[20]
|
Toyokuni, S. (2009) Role of Iron in Carcinogenesis: Cancer as a Ferro-toxic Disease. Cancer Science, 100, 9-16.
https://doi.org/10.1111/j.1349-7006.2008.01001.x
|
[21]
|
Yamaguchi, K., Mandai, M., Toyokuni, S., Hamanishi, J., Higuchi, T., Takakura, K. and Fujii, S. (2008) Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress. Clinical Cancer Research, 14, 32-40.
https://doi.org/10.1158/1078-0432.CCR-07-1614
|
[22]
|
杜媛媛, 王安生, 杨阳. 卵巢透明细胞癌从耐药机制到靶向药物选择的新进展[J]. 国际生殖健康/计划生育杂志, 2021, 40(4): 348-352.
|
[23]
|
Satoh, T., Hatae, M., Watanabe, Y., Yaegashi, N., Ishiko, O., Kodama, S., Yamaguchi, S., Ochiai, K., Takano, M., Yokota, H., et al. (2010) Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patients Election. Journal of Clinical Oncology, 28, 1727-1732. https://doi.org/10.1200/JCO.2009.24.8617
|
[24]
|
Website of National Comprehen-sive Cancer Network, USA (2019).
https://www.nccn.org/login?ReturnURL= https://www.nccn.org/professionals/physician
|
[25]
|
Website of Oxford Academic Journals (2019).
https://academic.oup.com/annonc/article-pdf/30/5/672/29189474/mdz062
|
[26]
|
Ozols, R.F., Bundy, B.N., Greer, B.E., Fowler, J.M., Clarke-Pearson, D., Burger, R.A., Mannel, R.S., DeGeest, K., Hartenbach, E.M., Baergen, R., et al. (2003) Phase III Trial of Carboplatin and Paclitaxel Compared with Cisplatin and Paclitaxel in Patients with Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology, 21, 3194-3200. https://doi.org/10.1200/JCO.2003.02.153
|
[27]
|
Mabuchi, S., Sugiyama, T., Kimura, T., et al. (2016) Clear Cell Carcinoma of the Ovary: Molecular Insights and Future Therapeutic Perspectives. Journal of Gynecologic Oncology, 27, e31. https://doi.org/10.3802/jgo.2016.27.e31
|
[28]
|
张国楠. 巢透卵明细胞癌的治疗策略与展望[J]. 中国实用妇科与产科杂志, 2021, 37(2): 193-197.
|
[29]
|
Hamanishi, J., Mandai, M., Ikeda, T., et al. (2015) Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients with Platinum-Resistant Ovarian Cancer. Journal of Clinical Oncology, 33, 4015-4022.
https://doi.org/10.1200/JCO.2015.62.3397
|
[30]
|
Disis, M.L., Patel, M.R., Pant, S., et al. (2015) Avelumab (MSB0010718C), an Anti-PD-L1 Antibody, in Patients with Previously Treated, Recurrent or Refractory Ovarian Can-cer: A Phase Ib, Open-Label Expansion Trial. Journal of Clinical Oncology, 33, 5509. https://doi.org/10.1200/jco.2015.33.15_suppl.5509
|